SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-161701
Filing Date
2017-05-08
Accepted
2017-05-08 07:12:33
Documents
4
Period of Report
2017-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d392910d8k.htm 8-K 13963
2 EX-99.1 d392910dex991.htm EX-99.1 325551
3 GRAPHIC g392910image001.jpg GRAPHIC 7676
4 GRAPHIC g392910img001.jpg GRAPHIC 7676
  Complete submission text file 0001193125-17-161701.txt   362198
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 17820562
SIC: 2834 Pharmaceutical Preparations